A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy Volunteers

Clinical trial NCT01857297 · COMPLETED

Trial details

NCT number: NCT01857297
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2013-05-01
Primary completion: 2013-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.